Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase I Study of LB-100 With Docetaxel in Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Lixte Biotechnology Holdings, Inc. Identifier:
First received: April 18, 2013
Last updated: January 23, 2017
Last verified: September 2016